Catalyst Wire Dossier Catalyst Wire Dossier

V590

V590 · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V590, covering 2021-12-29 to 2021-12-29. Get the full timeline:

Most recent: Clinical Trial Update: Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) [Phase 1]

See pricing